Abstract
The Agouti Related Protein (AgRP), Neuropeptide Y (NPY), Cocaine and Amphetamine-Regulated Transcript (CART), and Proopiomelanocortin hormone (POMC) are four essential neuropeptides that play an import role in regulation of food intake and energy homeostasis in mammals. Each of the two pairs of neuropeptides, AgRP / NPY and CART / POMC, are co-expressed in distinctly separate neurons in the hypothalamus. The four neuropeptides are also expressed widely in peripheral tissues with the adrenal gland being the major site of expression except in the case of NPY that is expressed predominantly in the prostate. There is abundant information regarding the physiological roles of these genes but there is limited information regarding their transcriptional regulation in the brain and the periphery. We employed multiple in silico methods from genome-wide applications and genomic sequence from promoter regions to predict common and unique regulatory patterns of transcription for these genes. hCART and hPOMC are phylogenetically closely related in terms of the common transcription factors (TFs) that were predicted for the two promoters, whereas hAgRP is a distant relative to hNPY. We also identified short regions (20 nucleotides or less) in the promoters of pairs of these genes that were 100% identical and are candidate TF binding sites. These studies provide a paradigm for analogous applications to other co-regulated genes and could lead to the identification of functional promoter targets for interventional therapies.
Keywords: agrp, npy, cart, pomc, transcription, promoter, tf, binding site
Current Genomics
Title: Deciphering Transcriptional Regulation Relevant to Eating Behavior
Volume: 4 Issue: 7
Author(s): D. M. Graunke and G. Argyropoulos
Affiliation:
Keywords: agrp, npy, cart, pomc, transcription, promoter, tf, binding site
Abstract: The Agouti Related Protein (AgRP), Neuropeptide Y (NPY), Cocaine and Amphetamine-Regulated Transcript (CART), and Proopiomelanocortin hormone (POMC) are four essential neuropeptides that play an import role in regulation of food intake and energy homeostasis in mammals. Each of the two pairs of neuropeptides, AgRP / NPY and CART / POMC, are co-expressed in distinctly separate neurons in the hypothalamus. The four neuropeptides are also expressed widely in peripheral tissues with the adrenal gland being the major site of expression except in the case of NPY that is expressed predominantly in the prostate. There is abundant information regarding the physiological roles of these genes but there is limited information regarding their transcriptional regulation in the brain and the periphery. We employed multiple in silico methods from genome-wide applications and genomic sequence from promoter regions to predict common and unique regulatory patterns of transcription for these genes. hCART and hPOMC are phylogenetically closely related in terms of the common transcription factors (TFs) that were predicted for the two promoters, whereas hAgRP is a distant relative to hNPY. We also identified short regions (20 nucleotides or less) in the promoters of pairs of these genes that were 100% identical and are candidate TF binding sites. These studies provide a paradigm for analogous applications to other co-regulated genes and could lead to the identification of functional promoter targets for interventional therapies.
Export Options
About this article
Cite this article as:
Graunke M. D. and Argyropoulos G., Deciphering Transcriptional Regulation Relevant to Eating Behavior, Current Genomics 2003; 4 (7) . https://dx.doi.org/10.2174/1389202033490150
DOI https://dx.doi.org/10.2174/1389202033490150 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
New Compounds Targeting the Androgen Receptor for Treatment of Advanced Prostate Cancer
Current Drug Targets Variation of Pharmacokinetic Profiles of Some Antidiabetic Drugs from Nanostructured Formulations Administered Through Pulmonary Route
Current Drug Metabolism Immunohistochemical Expression of Melatonin Receptor MT1 and Glucose Transporter GLUT1 in Human Breast Cancer
Anti-Cancer Agents in Medicinal Chemistry Nitric Oxide Synthase and Cyclooxygenase Pathways: A Complex Interplay in Cellular Signaling
Current Medicinal Chemistry Current Status and Future Perspectives of PI3K and mTOR Inhibitor as Anticancer Drugs in Breast Cancer
Current Cancer Drug Targets Applications of Nanosystems to Anticancer Drug Therapy (Part I. Nanogels, Nanospheres, Nanocapsules)
Recent Patents on Anti-Cancer Drug Discovery Molecular Chaperone ORP150 in ER Stress–related Diseases
Current Pharmaceutical Design Immunotherapy for Malignant Melanoma Robert
Current Stem Cell Research & Therapy Editorial on the Occasion of the 20th Anniversary of Endocrine Metabolic Immune Disorders-Drug Targets Journal with a Kaleidoscopic Vision of Selected Publications
Endocrine, Metabolic & Immune Disorders - Drug Targets Cardiovascular and Metabolic Effects of Ghrelin
Current Diabetes Reviews Meet the Editorial Board:
Current Drug Targets Prostaglandin E<sub>2</sub> Receptor 4 (EP4): A Promising Therapeutic Target for the Treatment of Cancer and Inflammatory Diseases
Current Chemical Biology Nutrient-By-Genotype Interactions and Personalized Diet: What Can We Learn From Drosophila and Evolutionary Biology?
Current Pharmacogenomics and Personalized Medicine Interaction between Gastric and Upper Small Intestinal Hormones in the Regulation of Hunger and Satiety: Ghrelin and Cholecystokinin Take the Central Stage
Current Protein & Peptide Science Therapeutic Potential for Thyroid Hormone Receptor-β Selective Agonists for Treating Obesity, Hyperlipidemia and Diabetes
Current Vascular Pharmacology Clinical and Translational Research Challenges in Neuroendocrine Tumours
Current Medicinal Chemistry NPY Y1 and Y5 Receptor Selective Antagonists as Anti-Obesity Drugs
Current Topics in Medicinal Chemistry Aberrant Activation of Arachidonic Acid and Eicosanoid Pathways-Targets for Treating Prostate Cancer
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Adult Neurogenic and Antidepressant Effects of Adiponectin: A Potential Replacement for Exercise
CNS & Neurological Disorders - Drug Targets CD40L - A Multipotent Molecule for Tumor Therapy
Endocrine, Metabolic & Immune Disorders - Drug Targets